Influence investigation by the pharmacist follow after the medicatio
Not Applicable
- Conditions
- Diabetes
- Registration Number
- JPRN-UMIN000042922
- Lead Sponsor
- others Chiba Pharmaceutical Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Not provided
Exclusion Criteria
The patient who receives visit drug management instruction The patient who cannot list the VAS method by a physical reason The patient who does not have legal representative
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method medication adherence
- Secondary Outcome Measures
Name Time Method The number of side effects Change of the HbA1c level Patient evaluation of the pharmacist follow